FDA applicant

Stemcell Technologies Canada, Inc.

Vancouver, CA1 decision2023–20230 recalls

FDA records 1 decision for Stemcell Technologies Canada, Inc. (Vancouver, CA) in 2023: 1 De Novo grant. All are in product code QYO (Hematopoietic Cell Enrichment Kit). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, immunology panel, where it files most

How often FDA has decided Stemcell Technologies Canada, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2023high 1 (2023) · low 0 (2024)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2023.

FIG. 1 — Stemcell Technologies Canada, Inc. by year, 2023–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Stemcell Technologies Canada, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Stemcell Technologies Canada, Inc.

Which product codes does it file in?

What has FDA decided for it lately?